STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 95 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $540,000 | -93.1% | 111,520 | -84.9% | 0.00% | -100.0% |
| Q4 2019 | $7,842,000 | +6327.9% | 737,706 | +6173.0% | 0.00% | – |
| Q3 2019 | $122,000 | -97.8% | 11,760 | -96.7% | 0.00% | -100.0% |
| Q2 2019 | $5,476,000 | +817.3% | 357,411 | +669.5% | 0.00% | – |
| Q1 2019 | $597,000 | -87.1% | 46,450 | -90.5% | 0.00% | -100.0% |
| Q4 2018 | $4,635,000 | -69.7% | 487,820 | -47.0% | 0.00% | -71.4% |
| Q3 2018 | $15,285,000 | +13.5% | 920,739 | +9.7% | 0.01% | 0.0% |
| Q2 2018 | $13,469,000 | +50.5% | 839,174 | +43.5% | 0.01% | +40.0% |
| Q1 2018 | $8,948,000 | +7889.3% | 584,873 | +5690.8% | 0.01% | – |
| Q3 2017 | $112,000 | -20.6% | 10,100 | -54.9% | 0.00% | – |
| Q4 2015 | $141,000 | +206.5% | 22,397 | +475.6% | 0.00% | – |
| Q2 2015 | $46,000 | +21.1% | 3,891 | +49.9% | 0.00% | – |
| Q1 2015 | $38,000 | +72.7% | 2,596 | +103.9% | 0.00% | – |
| Q4 2014 | $22,000 | -71.1% | 1,273 | -79.0% | 0.00% | – |
| Q3 2014 | $76,000 | -98.9% | 6,071 | -96.1% | 0.00% | -100.0% |
| Q3 2013 | $7,092,000 | – | 156,586 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|